Victorian futures trader jailed
A former Fasciale Futures Trading director has been sentenced in the Melbourne County Court to six years imprisonment on charges brought by the Australian Securities and Investments Commission (ASIC).
Spartaco Fasciale of Moonee Ponds, Victoria, will serve a minimum of four years after he was convicted by a jury on four counts of obtaining a financial advantage by deception, 10 counts of dishonestly obtaining property by deception and 14 counts of breaching directors’ duties following a two-week trial. He was found not guilty of a further count by direction of the court.
At the time of the offences Fasciale was the director of Fasciale Futures Trading, now in liquidation.
ASIC found between March 2004 and May 2006 nine people invested over $1.4 million with Fasciale Futures on the understanding that some of the funds would be traded on the Australian Securities Exchange and other money would be held in trust. Investors were also advised that Fasciale would generate returns between 3 and 5 per cent every month.
According to ASIC, Fasciale subsequently lost over $250,000 of investors’ money trading on futures contracts and used the remaining money to pay investors their returns as well as cover his own lifestyle expenses.
ASIC said Fasciale did not hold an Australian Financial Services (AFS) licence nor was he authorised to represent an AFS licensee.
AUTHOR
Mike Taylor
Recommended for you
With the final tally for FY25 now confirmed, how many advisers left during the financial year and how does it compare to the previous year?
HUB24 has appointed Matt Willis from Vanguard as an executive general manager of platform growth to strengthen the platform’s relationships with industry stakeholders.
Investment manager Drummond Capital Partners has announced a raft of adviser-focused updates, including a practice growth division, relaunched manager research capabilities, and a passive model portfolio suite.
When it comes to M&A activity, the share of financial buyers such as private equity firms in Australia fell from 67 per cent to 12 per cent in the last financial year.
